Business · 06/06/1996Updated: 10/18/2026 · 1 min read

Clinical Studies of Safety and Effectiveness of Orphan Products; Availability of Grants; Request for Applications

Summary

The Food and Drug Administration (FDA) is updating its Orphan Products Development (OPD) grant program for fiscal year 1997, replacing a previous announcement published in the Federal Register on August 15, 1994. The new announcement will outline program requirements, application deadlines, available funding, and the number of awards to be made annually.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Healthcare Business News Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News

Related business signals

Business · 9/16/2026

Microbiology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-Pathogen-Agnostic Sequencing

The Food and Drug Administration (FDA) announces a public advisory committee meeting of the Microbiology Devices Panel to discuss pathogen-agnostic sequencing for emergency preparedness and response efforts.

Read summary →

Business · 9/16/2026

Food and Drug Administration Announces Proposed Collection of Information for Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.

Read summary →

Business · 9/14/2026

FDA Submits Collection of Information for OMB Review

Read summary →

Business · 9/16/2026

Medicare Program; Public Meeting for New Revisions to the Healthcare Common Procedure Coding System (HCPCS) Level II Coding

The Centers for Medicare and Medicaid Services (CMS) will hold its second biannual Healthcare Common Procedure Coding System (HCPCS) Level II public meeting of 2026 to discuss new revisions to the HCPCS Level II code set for non-drug and non-biological items and services.

Read summary →

Business · 9/16/2026

Medicare Program; Medicare Appeals; Adjustment to the Amount in Controversy Threshold Amounts for Calendar Year 2027

The Medicare appeals process will adjust its amount in controversy threshold amounts for ALJ hearings and judicial review, effective January 1, 2027, with new thresholds of $200 for ALJ hearings and $2,000 for judicial review.

Read summary →

Business · 9/15/2026

OCSE Requests 3-Year Extension for Multistate Financial Institution Data Match Program

The Office of Child Support Enforcement is seeking a 3-year extension for the Multistate Financial Institution Data Match program, which matches financial data from federally assisted states with the Levy, a program that helps collect child support payments.

Read summary →